EE9800186A - Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett - Google Patents

Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett

Info

Publication number
EE9800186A
EE9800186A EE9800186A EE9800186A EE9800186A EE 9800186 A EE9800186 A EE 9800186A EE 9800186 A EE9800186 A EE 9800186A EE 9800186 A EE9800186 A EE 9800186A EE 9800186 A EE9800186 A EE 9800186A
Authority
EE
Estonia
Prior art keywords
fast
pharmaceutically acceptable
acceptable salt
release tablet
tablet containing
Prior art date
Application number
EE9800186A
Other languages
English (en)
Inventor
Hedevang Christensen Lars
Bols Pedersen S�ren
Erik Gebhardt-Hansen Knud
Bj�rnsdottir Karen
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of EE9800186A publication Critical patent/EE9800186A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9800186A 1995-12-20 1996-12-19 Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett EE9800186A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20
PCT/DK1996/000548 WO1997022340A1 (en) 1995-12-20 1996-12-19 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof

Publications (1)

Publication Number Publication Date
EE9800186A true EE9800186A (et) 1998-12-15

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800186A EE9800186A (et) 1995-12-20 1996-12-19 Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett

Country Status (27)

Country Link
US (1) US6036975A (et)
EP (1) EP0869783B1 (et)
JP (1) JP2000515489A (et)
CN (1) CN1147295C (et)
AR (1) AR004395A1 (et)
AT (1) ATE234085T1 (et)
AU (1) AU1190097A (et)
BR (1) BR9612057A (et)
CA (1) CA2244396A1 (et)
CZ (1) CZ293422B6 (et)
DE (1) DE69626676T2 (et)
DK (1) DK0869783T3 (et)
EE (1) EE9800186A (et)
ES (1) ES2191781T3 (et)
HR (1) HRP960598A2 (et)
HU (1) HU224030B1 (et)
IL (1) IL124356A (et)
MX (1) MX9803918A (et)
NO (1) NO316869B1 (et)
NZ (1) NZ324674A (et)
PL (1) PL186915B1 (et)
RO (1) RO117589B1 (et)
RU (1) RU2166939C2 (et)
TR (1) TR199801126T2 (et)
TW (1) TW430561B (et)
WO (1) WO1997022340A1 (et)
ZA (1) ZA9610714B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
MXPA02005562A (es) * 1999-12-06 2004-09-10 Penwest Pharmaceuticals Co Superdesintegrante farmaceutico.
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20050084914A1 (en) * 2003-09-15 2005-04-21 Foulkes J. G. Assays with primary cells
US20070259829A1 (en) * 2006-03-24 2007-11-08 Maen Abdelrahim Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
JP2019529534A (ja) * 2016-09-07 2019-10-17 セルジーン コーポレイション 錠剤組成物
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (et) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
JP2000515489A (ja) 2000-11-21
NO982875L (no) 1998-08-19
TR199801126T2 (xx) 1998-08-21
DK0869783T3 (da) 2003-06-02
NZ324674A (en) 2000-01-28
ATE234085T1 (de) 2003-03-15
CN1208345A (zh) 1999-02-17
RU2166939C2 (ru) 2001-05-20
CA2244396A1 (en) 1997-06-26
PL327584A1 (en) 1998-12-21
NO982875D0 (no) 1998-06-19
DE69626676D1 (de) 2003-04-17
BR9612057A (pt) 1999-02-23
US6036975A (en) 2000-03-14
IL124356A0 (en) 1998-12-06
RO117589B1 (ro) 2002-05-30
HUP9903410A2 (hu) 2000-04-28
CZ194398A3 (cs) 1998-11-11
NO316869B1 (no) 2004-06-07
WO1997022340A1 (en) 1997-06-26
PL186915B1 (pl) 2004-03-31
TW430561B (en) 2001-04-21
HRP960598A2 (en) 1998-02-28
AR004395A1 (es) 1998-11-04
ZA9610714B (en) 1997-06-30
IL124356A (en) 2001-05-20
MX9803918A (es) 1998-09-30
HUP9903410A3 (en) 2000-05-29
AU1190097A (en) 1997-07-14
CN1147295C (zh) 2004-04-28
HU224030B1 (hu) 2005-05-30
CZ293422B6 (cs) 2004-04-14
ES2191781T3 (es) 2003-09-16
EP0869783B1 (en) 2003-03-12
EP0869783A1 (en) 1998-10-14
DE69626676T2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
NO973612D0 (no) Nytt farmasöytisk preparat
NO2009004I2 (no) Mavacoxib eller et farmasøytisk akseptabelt salt derav
NO2009028I2 (no) Gefitinib eller et farmasøytisk akseptabelt salt derav
DK0840634T3 (da) Transcornealt lægemiddelfrigivelsessystem
FI973002A (fi) Terapeuttinen yhdiste - rasvahappokonjugaatit
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
NO943888D0 (no) Farmasöytisk preparat
IS5869A (is) Hraðlosandi tafla
NO2010003I1 (no) Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
BR9610396A (pt) Formulação farmacêutica
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
BR9610214A (pt) Compostos farmacéuticos
EE9800186A (et) Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett
DE69626463D1 (de) Sicherungseinheit
NO973610D0 (no) Nytt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
PT850048E (pt) Granulos farmaceuticos
FI951155A (fi) Farmaseuttinen valmiste
NO965448D0 (no) Farmasöytiske forbindelser
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
BR9603673A (pt) Preparado de combinação farmacêutica compreendendo cetoprofeno
DE29517296U1 (de) Medikamententimer
UA1292S (uk) Таблетка фармацевтична
SE9302429D0 (sv) New pharmaceutical preparation ii